Griffiths Amends Silence Therapeutics Stake

TL;DR

Griffiths just updated his Silence Therapeutics stake filing. Watch this space.

AI Summary

On March 27, 2024, Richard Ian Griffiths filed an amendment (No. 4) to Schedule 13D for Silence Therapeutics plc. This filing indicates a change in beneficial ownership of the company's ordinary shares. The specific details of the change in ownership and the total percentage held are not fully detailed in this excerpt.

Why It Matters

Changes in significant beneficial ownership can signal shifts in investor sentiment or potential strategic moves regarding the company.

Risk Assessment

Risk Level: medium — Schedule 13D filings often relate to significant ownership changes, which can introduce volatility and uncertainty.

Key Players & Entities

• Silence Therapeutics plc (company) — Subject Company
• Richard Ian Griffiths (person) — Filing Person
• Richard Griffiths (person) — Person Authorized to Receive Notices
• ORA CAPITAL LTD (company) — Group Member

FAQ

Key Financial Figures

• $38.7M — 7, 2024 for aggregate gross proceeds of $38.7M. Mr. Griffiths purchased an aggregate o
• $1.4M — uary 30, 2024 for an aggregate price of $1.4M. All purchases were for cash and were f

Filing Documents

• d792279dsc13da.htm (SC 13D/A) — 84KB
• d792279dex99a.htm (EX-99.A) — 3KB
• 0001193125-24-078938.txt ( ) — 88KB

is hereby amended and restates as follows

Item 2 is hereby amended and restates as follows: (a) This Schedule 13D is filed by Richard Ian Griffiths (Mr. Griffiths) and Ora Capital Limited (Ora and, with Mr. Griffiths, collectively, the Reporting Persons). The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13D. (b) The principal business office of the Reporting Persons is Floor 1 Liberation Station, Esplanade, St Helier, Jersey, JE2 3AS. (c) The principal business of Ora is capital investments. The principal business of Mr. Griffiths is serving as chairman of Sarossa Plc and Ora Limited. (d) During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, none of the Reporting Persons was a party to a civil proceeding of a judicial of administrative body of competent jurisdiction or were subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Ora was organized under the laws of Jersey and Mr. Griffiths is a citizen of Jersey, Channel Islands. Item3. Source and Amount of Funds or Other Consideration

is hereby amended and supplemented as follows

Item 3 is hereby amended and supplemented as follows: Mr. Griffiths sold an aggregate of 1,870,182 ADSs in open market transactions between August 20, 2023 and March 27, 2024 for aggregate gross proceeds of $38.7M. Mr. Griffiths purchased an aggregate of 199,131 ADSs in open market transactions between August 22, 2023 and January 30, 2024 for an aggregate price of $1.4M. All purchases were for cash and were funded by personal funds of Mr. Griffiths. Item5. Interest in Securities of the Issuer

is hereby amended and restated as follows

Item 5 is hereby amended and restated as follows: (a)-(b) Rows (7) through (13) of the cover pages of this Schedule 13D are hereby incorporated by reference. (c) Except as set forth in Schedule 1, none of the Reporting Persons has effected any transactions in the Issuers Ordinary Shares or ADSs during the last 60 days. (d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, the Ordinary Shares or ADSs beneficially owned by any of the Reporting Persons. (e) Not applicable. Item7. Material to be Filed as Exhibits

is hereby amended and restated as follows

Item 7 is hereby amended and restated as follows: A. Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: March 27, 2024 Ora Capital Limited By: /s/ Richard Ian Griffiths Name: Richard Ian Griffiths Title: Director Richard Ian Griffiths /s/ Richard Ian Griffiths Schedule 1 Transactions in ADSs During the Past Sixty Days Date Nature of the Transaction Reporting Person Amount of Securities Purchased/Sold Price 01/26/24 Purchase Richard Griffiths 3,000 $ 18.70 01/29/24 Purchase Richard Griffiths 5,400 $ 19.06 01/30/24 Purchase Richard Griffiths 1,512 $ 18.90 02/07/24 Sale Richard Griffiths (20,670 ) $ 16.65 02/08/24 Sale Richard Griffiths (330,000 ) $ 16.58 02/23/24 Sale Richard Griffiths (48,965 ) $ 18.63 02/26/24 Sale Richard Griffiths (131,547 ) $ 18.53 02/27/24 Sale Richard Griffiths (25,000 ) $ 24.84 02/27/24 Sale Richard Griffiths (100 ) $ 18.87 02/27/24 Sale Richard Griffiths (88,097 ) $ 19.31 02/28/24 Sale Richard Griffiths (36,122 ) $ 24.84 02/28/24 Sale Richard Griffiths (49,348 ) $ 25.59 02/28/24 Sale Richard Griffiths (248,000 ) $ 20.14 02/29/24 Sale Richard Griffiths (63,723 ) $ 25.67 02/29/24 Sale Richard Griffiths (26,113 ) $ 25.40 02/29/24 Sale Richard Griffiths (58,694 ) $ 20.14 03/01/24 Sale Richard Griffiths (58,754 ) $ 25.44 03/01/24 Sale Richard Griffiths (25,000 ) $ 25.45 03/01/24 Sale Richard Griffiths (62,811 ) $ 20.12 03/04/24 Sale Richard Griffiths (41,513 ) $ 25.47 03/04/24 Sale Richard Griffiths (25,000 ) $ 20.47 03/05/24 Sale Richard Griffiths (2

View Full Filing

View this SC 13D/A filing on SEC EDGAR